Ulrich G. Traugott
Keine laufenden Positionen mehr
Profil
Ulrich G.
Traugott worked as a Director of Medicine at Atugen AG, Medical Director at Glaxo Wellcome, Director of Medical Oncology at Knoll Pharmaceutical Co., and Manager of Clinical Research at Genentech, Inc. He holds a graduate and doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Ehemalige bekannte Positionen von Ulrich G. Traugott
| Unternehmen | Position | Ende |
|---|---|---|
| Knoll Pharmaceutical Co. | Corporate Officer/Principal | - |
| Glaxo Wellcome, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ulrich G. Traugott
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Atugen AG
Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Knoll Pharmaceutical Co. |
